Main issues in penetrating keratoplasty

IF 1 Q4 OPHTHALMOLOGY
Jorge L. Alió, Sana Niazi, Farideh Doroodgar, J. D. Barrio, Hassan Hashemi, Mohammad Ali Javadi
{"title":"Main issues in penetrating keratoplasty","authors":"Jorge L. Alió, Sana Niazi, Farideh Doroodgar, J. D. Barrio, Hassan Hashemi, Mohammad Ali Javadi","doi":"10.4103/tjo.tjo-d-24-00001","DOIUrl":null,"url":null,"abstract":"\n This review explores contemporary challenges in penetrating keratoplasty (PK), focusing on technical intricacies, technological advancements, and strategies for preventing graft rejection. A systematic literature search from January 2018 to July 2023 was conducted across PubMed, Cochrane, Web of Science, Scopus, and EMBASE. The inclusion criteria comprised studies on PK and its comparison with other corneal pathologies, with emphasis on keratoconus (KC). Two independent reviewers screened studies, extracting relevant data. The review covers PK evolution, highlighting infra-red femtosecond lasers’ impact on graft shapes, minimizing astigmatism, and enhancing wound healing. Graft rejection, a primary complication, is examined, detailing risk factors and preventive measures. Preoperative considerations, diagnostic techniques for rejection, and PK in KC are discussed. Postoperative care’s significance, including intraocular pressure monitoring and steroid administration, is emphasized. The paper concludes with a comprehensive approach to prevent graft rejection, involving topical and systemic medications. An outlook on evolving monoclonal antibody research is presented. As the field progresses, personalized approaches and ongoing therapeutic exploration are expected to refine strategies, enhancing PK outcomes.","PeriodicalId":44978,"journal":{"name":"Taiwan Journal of Ophthalmology","volume":null,"pages":null},"PeriodicalIF":1.0000,"publicationDate":"2024-02-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Taiwan Journal of Ophthalmology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4103/tjo.tjo-d-24-00001","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"OPHTHALMOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

This review explores contemporary challenges in penetrating keratoplasty (PK), focusing on technical intricacies, technological advancements, and strategies for preventing graft rejection. A systematic literature search from January 2018 to July 2023 was conducted across PubMed, Cochrane, Web of Science, Scopus, and EMBASE. The inclusion criteria comprised studies on PK and its comparison with other corneal pathologies, with emphasis on keratoconus (KC). Two independent reviewers screened studies, extracting relevant data. The review covers PK evolution, highlighting infra-red femtosecond lasers’ impact on graft shapes, minimizing astigmatism, and enhancing wound healing. Graft rejection, a primary complication, is examined, detailing risk factors and preventive measures. Preoperative considerations, diagnostic techniques for rejection, and PK in KC are discussed. Postoperative care’s significance, including intraocular pressure monitoring and steroid administration, is emphasized. The paper concludes with a comprehensive approach to prevent graft rejection, involving topical and systemic medications. An outlook on evolving monoclonal antibody research is presented. As the field progresses, personalized approaches and ongoing therapeutic exploration are expected to refine strategies, enhancing PK outcomes.
穿透性角膜移植术的主要问题
本综述探讨了穿透性角膜移植术(PK)的当代挑战,重点关注技术的复杂性、技术的进步以及预防移植物排斥反应的策略。从 2018 年 1 月到 2023 年 7 月,我们在 PubMed、Cochrane、Web of Science、Scopus 和 EMBASE 上进行了系统的文献检索。纳入标准包括有关 PK 的研究及其与其他角膜病变的比较,重点是角膜屈光不正(KC)。两位独立审稿人对研究进行了筛选,提取了相关数据。综述涵盖了PK的演变,重点介绍了红外飞秒激光对移植物形状、散光最小化和促进伤口愈合的影响。对移植物排斥这一主要并发症进行了研究,详细介绍了风险因素和预防措施。还讨论了术前注意事项、排斥反应诊断技术和 KC 中的 PK。本文强调了术后护理的重要性,包括眼压监测和类固醇用药。最后,本文介绍了预防移植排斥反应的综合方法,包括局部用药和全身用药。本文还对不断发展的单克隆抗体研究进行了展望。随着该领域的不断进步,个性化方法和持续的治疗探索有望完善策略,提高 PK 结果。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
1.80
自引率
9.10%
发文量
68
审稿时长
19 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信